Research ArticleSystemic lupus erythematosus
Open Access
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus
Sarfaraz Hasni, Yenealem Temesgen-Oyelakin, Michael Davis, Jun Chu, Elaine Poncio, Mohammad Naqi, Sarthak Gupta, Xinghao Wang, Christopher Oliveira, Dillon Claybaugh, Amit Dey, Shajia Lu, Philip Carlucci, Monica Purmalek, Zerai G Manna, Yinghui Shi, Isabel Ochoa-Navas, Jinguo Chen, Amrita Mukherjee, Kyu Lee Han, Foo Cheung, Galina Koroleva, Yasmine Belkaid, John S Tsang, Richard Apps, Donald E Thomas, Theo Heller, Massimo Gadina, Martin P Playford, Xiaobai Li, Nehal N Mehta and Mariana J Kaplan
Annals of the Rheumatic Diseases August 2022, annrheumdis-2022-222658; DOI: https://doi.org/10.1136/ard-2022-222658
Sarfaraz Hasni
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Yenealem Temesgen-Oyelakin
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Michael Davis
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Jun Chu
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Elaine Poncio
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Mohammad Naqi
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Sarthak Gupta
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Xinghao Wang
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Christopher Oliveira
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Dillon Claybaugh
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Amit Dey
3
Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
Shajia Lu
4
Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA
Philip Carlucci
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Monica Purmalek
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Zerai G Manna
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Yinghui Shi
5
Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA
Isabel Ochoa-Navas
1
Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Jinguo Chen
6
National Institutes of Health, Bethesda, Maryland, USA
Amrita Mukherjee
6
National Institutes of Health, Bethesda, Maryland, USA
Kyu Lee Han
6
National Institutes of Health, Bethesda, Maryland, USA
Foo Cheung
6
National Institutes of Health, Bethesda, Maryland, USA
Galina Koroleva
6
National Institutes of Health, Bethesda, Maryland, USA
Yasmine Belkaid
7
Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
John S Tsang
8
Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, National Institutes of Health, Bethesda, Maryland, USA
9
NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA
Richard Apps
6
National Institutes of Health, Bethesda, Maryland, USA
Donald E Thomas
10
Arthritis and Pain Associates of PG County, Greenbelt, Maryland, USA
Theo Heller
11
NIDDK, National Institutes of Health, Bethesda, Maryland, USA
Massimo Gadina
12
NIAMS, National Institutes of Health, Bethesda, Maryland, USA
Martin P Playford
13
National Heart Lung and Blood Institute, Bethesda, Maryland, USA
Xiaobai Li
14
Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA
Nehal N Mehta
6
National Institutes of Health, Bethesda, Maryland, USA
Mariana J Kaplan
2
Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA

Article Information
annrheumdis-2022-222658
Published By
Print ISSN
Online ISSN
Copyright & Usage
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Citation Metrics
Funding
National Institute of Allergy and Infectious Diseases
Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health
ZIAAR041199
In this issue
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus
Sarfaraz Hasni, Yenealem Temesgen-Oyelakin, Michael Davis, Jun Chu, Elaine Poncio, Mohammad Naqi, Sarthak Gupta, Xinghao Wang, Christopher Oliveira, Dillon Claybaugh, Amit Dey, Shajia Lu, Philip Carlucci, Monica Purmalek, Zerai G Manna, Yinghui Shi, Isabel Ochoa-Navas, Jinguo Chen, Amrita Mukherjee, Kyu Lee Han, Foo Cheung, Galina Koroleva, Yasmine Belkaid, John S Tsang, Richard Apps, Donald E Thomas, Theo Heller, Massimo Gadina, Martin P Playford, Xiaobai Li, Nehal N Mehta, Mariana J Kaplan
Annals of the Rheumatic Diseases Aug 2022, annrheumdis-2022-222658; DOI: 10.1136/ard-2022-222658
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus
Sarfaraz Hasni, Yenealem Temesgen-Oyelakin, Michael Davis, Jun Chu, Elaine Poncio, Mohammad Naqi, Sarthak Gupta, Xinghao Wang, Christopher Oliveira, Dillon Claybaugh, Amit Dey, Shajia Lu, Philip Carlucci, Monica Purmalek, Zerai G Manna, Yinghui Shi, Isabel Ochoa-Navas, Jinguo Chen, Amrita Mukherjee, Kyu Lee Han, Foo Cheung, Galina Koroleva, Yasmine Belkaid, John S Tsang, Richard Apps, Donald E Thomas, Theo Heller, Massimo Gadina, Martin P Playford, Xiaobai Li, Nehal N Mehta, Mariana J Kaplan
Annals of the Rheumatic Diseases Aug 2022, annrheumdis-2022-222658; DOI: 10.1136/ard-2022-222658